期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

防癌筛查妇女中人乳头状瘤病毒感染状况分析 被引量：4

An Analysis on HPV Infection Status in Screened Women
原文传递
导出
摘要 [目的]了解防癌筛查妇女中HPV感染状况及分布特点,为宫颈癌防治提供依据。[方法]采用HybriMax技术对5880例防癌筛查妇女进行HPV感染检测。[结果 ]5880例防癌筛查妇女中HPV阳性1105例,阳性率为18.80%,21种型别均被检测出。高危型以HPV16、HPV52和HPV58最常见,低危型最常见的为HPV53和HPVcp8304。阳性感染者中228例为多重感染,多重感染率为3.88%(228/5880),占阳性例数的20.63%,其中二重感染最多见。[结论]HPV亚型感染分布以HPV16、HPV52和HPV58为主,其分布与宫颈癌前病变及宫颈癌密切相关。 [Purpose] To investigate the HPV infection status and age distribution in screened women,to provide basis for prevention and control of cervical cancer. [Methods] A total number of 5880cases were detected for HPV by HybriMax. [Results] The number of positive cases was 1105 out of5880. Positive rate of HPV infection was 18.80%. All the 21 genotypes of HPV were tested out. The most common high-risk genotype were HPV16,HPV52 and HPV58,whereas HPV16 and HPVcp8304 were the most common low-risk genotypes. The multiple infection rate was 3.88%（228/5880）. Double infection was common. [Conclusion] HPV16,HPV52 and HPV58 serves as the most common genotypes in HPV. The HPV distribution closely correlates to cervical precancerous lesions and cervical cancer.
作者 魏葆珺 李学祥 齐军
机构地区 中国医学科学院肿瘤医院肿瘤研究所
出处 《中国肿瘤》 CAS 2013年第11期885-887,共3页 China Cancer
关键词 人乳头状瘤病毒 导流杂交 筛查 宫颈癌 human papillomavirus HybriMax screening cervical cancer
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1Walboomers JM,Jacobs MV,Manos MM,et al.Human pa- pillomavirus is necessary a cause of invasive cervical cancer worldwide[J]. J Pathol, 1999,189(1):12-19.
  • 2Dell G, Gaston K. Human papillomavirus and their role in cervical cancer[J]. Cell Mol Life Sci,2001,58(12-13): 1923 - 1942.
  • 3梁德光,何之恒,蓝柯.人乳头瘤病毒及其致瘤机制的研究进展[J].生命科学,2008,20(6):843-848. 被引量：17
  • 4Wu RF,Dai M,Qiao YL,et al. Human papillomavirus in- fection in women in Shenzhen city,People's Republic of China,a population typical of recent Chinese urbani-sation [J]. Int J Cancer,2007,121(6):1306-1311.
  • 5Lin H,Ma YY,Moh JS,et al. High prevalence of genital human papvillomavirus type 52 and 58 infection in women attending gynecologic practioners in South Taiwan[J]. Gy- necol Oncol, 2006,101 (1):40-45.
  • 6Dai M, Bao YP, Li N,et al. Human papillomavirus infection in Shanxi province,People's Republic of China: a popula- tion-based study[J]. Br J Cancer, 2006,95(1):96-101.
  • 7Li Y,Wang Y,Jia C,et al. Detection of human papillo- mavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients[J].Cancer Genet Cyto- genet, 2008,182(1): 12-17.
  • 8Zhao FH,Lin MJ,Chen F,et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient da- ta from 17 population-based studies from China[J]. Lancet Oncol,2010,11(12):1160-1171.

二级参考文献38

  • 1Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep, 2007, 56(RR-2): 1-24
  • 2Wang Q, Griffin H, Southern S, et al. Functional analysis of the human papillomavirus type 16 E1=EA protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol, 2004, 78(2): 821-33
  • 3Boulet G, Horvath C, Vanden Broeck D, et al. Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol, 2007, 39(11): 2006-11
  • 4Liu X, Clements A, Zhao KH, et al. Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem, 2006, 281(1): 578-86
  • 5de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology, 2004, 324(1): 17-27
  • 6Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol, 2008, 110(3 Suppl 2): S4-7
  • 7An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer, 2003, 97(7): 1672-80
  • 8Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 2006, 24 Suppl 3:S3/26-34
  • 9Kurman RJ, Malkasian GD, Jr. Sedlis A, et al. From papanicolaou to bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol, 1991, 77(5): 779- 82
  • 10Clarke DT, Irving AT, Lambley EH, et al. A novel method for screening viral interferon-resistance genes. J Interferon Cytokine Res, 2004, 24(8): 470-7

共引文献16

同被引文献39

  • 1吴瑞芳,刘植华,周庆芝,乌兰娜,王倩,李晴,李霓,刘志红,石菊芳,李瑞珍,张长淮,周艳秋,刘彬,翁雷明,乔友林.深圳女性生殖道人乳头瘤病毒感染与子宫颈上皮内瘤样病变现患率调查及子宫颈癌筛查方法的评价[J].中国医学科学院学报,2010,32(1):90-95. 被引量：57
  • 2姜淑清,土送爱,周俊兰,买热木尼沙汗,碧佳娜提,茹仙姑丽,沙来买提,徐雪,海日尼沙汗,艾木热汗.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,21(4):524-526. 被引量：50
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 4International Agency for Research on Cancer. World cancer report 2014[D]. Geneva: WHO, 2014.
  • 5Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64( 1 ) :9 - 29.
  • 6Bray F, Parkin DM. Evaluation of data quality in the cancer regis- try: Principles and methods. Part Ⅰ : Comparability, validity and timeliness [ J ]. Eur J Cancer, 2009, 45 (5) :747 - 755.
  • 7Parkin DM, Chen VW, Ferlay J,et al. Comparability and Quality Control in Cancer Registration. IARC Technical Report No. 19 [ M ]. Lyon : IARC, 1994.
  • 8Felay J, Burkhard C, Whelan S,et al. Check and ConversionPro- grams for Cancer Registries. IARC Technical Report No. 42 [ M ]. Lyon : IARC ,2005.
  • 9Felay J. The IARCcrgTools program [ EB/OL]. http://www, ia- cr. com. fr/iarcergtools, htm. IACR. Lyon. 2006.
  • 10Tramacere I, Negri E, Pelucchi C, et al. A meta-analysis on alco- hol drinking and gastric cancer risk [ J ]. Ann Oncol, 2012,23 (1) :28 -36.

引证文献4

二级引证文献18

中国肿瘤
2013年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部